Patents by Inventor Liang-Shun WANG

Liang-Shun WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230149308
    Abstract: The present invention pertains to a pharmaceutical, or nutraceutical, “self-emulsifying solid dispersion” composition for oral administration which contains (a) a drug or a nutraceutical that is water-insoluble or poorly water-soluble; (b) at least one surfactant; (c) one carrier selected from the group consisting of silicic acid, a silicate, or any combination thereof; and (d) at least one carbohydrate filler.
    Type: Application
    Filed: January 18, 2023
    Publication date: May 18, 2023
    Applicant: HUANA GLOBAL BIOTECH CO., LTD.
    Inventors: Liang-Shun WANG, Chih-Chiang YANG, Yu-Hsuan LIN, Ping-Chuan FU
  • Publication number: 20200383912
    Abstract: The present invention pertains to a pharmaceutical, or nutraceutical, “self-emulsifying solid dispersion” composition for oral administration which contains (a) a drug or a nutraceutical that is water-insoluble or poorly water-soluble; (b) at least one surfactant; (c) one carrier selected from the group consisting of silicic acid, a silicate, or any combination thereof; and (d) at least one carbohydrate filler.
    Type: Application
    Filed: December 16, 2019
    Publication date: December 10, 2020
    Applicant: HUANA GLOBAL BIOTECH CO., LTD.
    Inventors: Liang-Shun Wang, Chih-Chiang Yang, Yu-Hsuan Lin, Ping-Chuan Fu
  • Patent number: 10478468
    Abstract: Disclosed is a method for enhancing the effect of an immunotherapy for cancer in a subject, comprising administering to the subject an effective amount of a polysaccharide extract of Astragalus membranaceus. Also disclosed is a method for increasing a subject's pool of M1 macrophages, wherein the subject is suffering from one or more conditions associated with undesirable M2 macrophage activation, the method comprising administering to the subject an effective amount of a polysaccharide extract of Astragalus membranaceus.
    Type: Grant
    Filed: November 9, 2017
    Date of Patent: November 19, 2019
    Assignee: PHYTOHEALTH CORPORATION
    Inventors: Liang-Shun Wang, Chi-Tai Yeh, Chun-Hung Wu, Yi-Li Lee
  • Publication number: 20180125912
    Abstract: Disclosed is a method for enhancing the effect of an immunotherapy for cancer in a subject, comprising administering to the subject an effective amount of a polysaccharide extract of Astragalus membranaceus. Also disclosed is a method for increasing a subject's pool of M1 macrophages, wherein the subject is suffering from one or more conditions associated with undesirable M2 macrophage activation, the method comprising administering to the subject an effective amount of a polysaccharide extract of Astragalus membranaceus.
    Type: Application
    Filed: November 9, 2017
    Publication date: May 10, 2018
    Applicant: PHYTOHEALTH CORPORATION
    Inventors: Liang-Shun WANG, Chi-Tai YEH, Chun-Hung WU, Yi-Ii LEE